Theriva Biologics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Theriva Biologics, Inc. (TOVX) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2026-03-12
- Theriva Biologics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2022-06-30 was 0.00%.
- Theriva Biologics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2019-03-31 was 0.00%.
- Theriva Biologics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2017-03-31 was 0.00%.
- Theriva Biologics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2016-06-30 was 0.00%.
- Theriva Biologics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2025 was 0.00%.
- Theriva Biologics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2024 was 0.00%.
- Theriva Biologics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2023 was 0.00%.
- Theriva Biologics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2022 was 0.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month |
|---|---|---|---|---|
| 2025-12-31 | 0.00% 10-K · filed 2026-03-12 | |||
| 2024-12-31 | 0.00% 10-K · filed 2026-03-12 | |||
| 2023-12-31 | 0.00% 10-K · filed 2025-03-06 | |||
| 2022-12-31 | 0.00% 10-K · filed 2024-03-25 | |||
| 2022-09-30 | 0.00% 10-Q · filed 2022-11-10 | |||
| 2022-06-30 | 0.00% 10-Q · filed 2022-08-11 | 0.00% 10-Q · filed 2022-08-11 | ||
| 2021-12-31 | 0.00% 10-K · filed 2023-03-30 | |||
| 2020-12-31 | 0.00% 10-K · filed 2022-03-16 | |||
| 2019-12-31 | 0.00% 10-K · filed 2021-03-04 | |||
| 2019-06-30 | 0.00% 10-Q · filed 2019-08-08 | |||
| 2019-03-31 | 0.00% 10-Q · filed 2019-05-08 | |||
| 2018-12-31 | 0.00% 10-K · filed 2020-02-20 | |||
| 2018-09-30 | 0.00% 10-Q · filed 2018-11-08 | |||
| 2017-12-31 | 0.00% 10-K · filed 2019-02-27 | |||
| 2017-09-30 | 0.00% 10-Q · filed 2017-11-01 | |||
| 2017-06-30 | 0.00% 10-Q · filed 2018-08-08 | |||
| 2017-03-31 | 0.00% 10-Q · filed 2018-05-08 | |||
| 2016-12-31 | 0.00% 10-K · filed 2018-02-22 | |||
| 2016-09-30 | 0.00% 10-Q · filed 2017-11-01 | |||
| 2016-06-30 | 0.00% 10-Q · filed 2016-08-03 | 0.00% 10-Q · filed 2017-08-03 | ||
| 2016-03-31 | 0.00% 10-Q · filed 2017-05-04 | |||
| 2015-12-31 | 0.00% 10-K · filed 2018-02-22 | |||
| 2015-09-30 | 0.00% 10-Q · filed 2015-11-05 | 0.00% 10-Q · filed 2016-11-01 | ||
| 2015-06-30 | 0.00% 10-Q · filed 2016-08-03 | 0.00% 10-Q · filed 2016-08-03 | ||
| 2015-03-31 | 0.00% 10-Q · filed 2016-05-05 | |||
| 2014-12-31 | 0.00% 10-K · filed 2017-03-02 | |||
| 2014-09-30 | 0.00% 10-Q · filed 2015-11-05 | 0.00% 10-Q · filed 2015-11-05 | ||
| 2014-06-30 | 0.00% 10-Q · filed 2015-08-10 | 0.00% 10-Q · filed 2015-08-10 | ||
| 2014-03-31 | 0.00% 10-Q · filed 2015-05-11 | |||
| 2013-12-31 | 0.00% 10-K · filed 2016-03-10 | |||
| 2013-09-30 | 0.00% 10-Q · filed 2014-11-14 | 0.00% 10-Q · filed 2014-11-14 | ||
| 2013-06-30 | 0.00% 10-Q · filed 2014-08-14 | 0.00% 10-Q · filed 2014-08-14 | ||
| 2013-03-31 | 0.00% 10-Q · filed 2014-05-15 | |||
| 2012-12-31 | 0.00% 10-K · filed 2015-03-16 | |||
| 2012-09-30 | 0.00% 10-Q · filed 2013-11-14 | 0.00% 10-Q · filed 2013-11-14 | ||
| 2012-06-30 | 0.00% 10-Q · filed 2013-08-14 | 0.00% 10-Q · filed 2013-08-14 | ||
| 2012-03-31 | 0.00% 10-Q · filed 2013-05-15 | |||
| 2011-12-31 | 0.00% 10-K · filed 2013-04-16 | |||
| 2011-09-30 | 0.00% 10-Q · filed 2012-11-14 | 0.00% 10-Q · filed 2012-11-14 | ||
| 2011-06-30 | 0.00% 10-Q/A · filed 2012-09-11 | 0.00% 10-Q/A · filed 2012-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |